Advenchen Laboratories
Moorpark · Founded 2003
About Advenchen Laboratories
Advenchen Laboratories is a small pharmaceutical company focusing on pharmaceutical research and development involving small molecule cancer drug discovery programs. Our scientists are looking for small molecule kinase inhibitors, especially protein tyrosine kinases (PTK) inhibitors, that target the regulation of various PTK for cancer treatment. Our proprietary drug development product pipeline has demonstrated strong anti-tumor activities and therapeutic benefits in various target scopes. It is believed that our novel small molecules will bring breakthrough and promising therapies as well as a prosperous future for cancer patients.
Company Facts
- Founded: 2003
- Legal name: Advenchen Laboratories LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $4.5M
- Last round: Series Unknown (May 2010)
- Website: advenchen.com
- Phone: 805-530-1550
Social Profiles
Canonical: https://fsome.com/organization/advenchen-laboratories-8449456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.